Hangartner Kevin, Bajka Anahita, Wiest Maximilian R J, Sidhu Sophia, Toro Mario D, Maloca Peter M, Zweifel Sandrine A
Faculty of Human Medicine, University of Zurich, 8032 Zurich, Switzerland.
Department of Ophthalmology, University Hospital of Zurich, University of Zurich, 8091 Zurich, Switzerland.
Diagnostics (Basel). 2023 Jul 27;13(15):2496. doi: 10.3390/diagnostics13152496.
Vessel tortuosity (VT) is a parameter used to assess retinal involvement in patients affected by systemic diseases such as Fabry disease (FD). In this study, we assessed a retinal VT index (VTI) using optical coherence tomography angiography (OCTA) in a group of patients with FD (FD cohort) compared to a healthy control group (HC cohort). This is a single-center, retrospective study analysis of all consecutive patients with genetically tested and confirmed FD who underwent regular ophthalmological visits from December 2017 to January 2020 at the Department of Ophthalmology at the University Hospital of Zurich, Switzerland. VTI was calculated for each OCTA image and the results were compared between FD and HC cohort. A total of 56 participants, 32 (male:female ratio 12:20) in the FD cohort and 24 (male:female ratio 13:11) in the HC cohort. Classic onset was determined in 18 patients. Overall, mean VTI (±SD) was 0.21 (±0.07). Male patients with classic-onset FD had a significantly higher mean VTI (0.33, SD ± 0.35) compared to all other subgroups (-value < 0.05). Further investigations of retinal VTI in patients with FD could be helpful to use OCTA as a noninvasive screening and follow-up modality to assess disease progression in affected patients.
血管迂曲(VT)是用于评估受法布里病(FD)等全身性疾病影响患者视网膜受累情况的一个参数。在本研究中,我们使用光学相干断层扫描血管造影(OCTA)对一组法布里病患者(FD队列)与健康对照组(HC队列)进行了视网膜VT指数(VTI)评估。这是一项单中心回顾性研究,分析了2017年12月至2020年1月期间在瑞士苏黎世大学医院眼科接受定期眼科检查且经基因检测确诊为法布里病的所有连续患者。为每张OCTA图像计算VTI,并比较FD队列和HC队列的结果。共有56名参与者,FD队列32名(男女比例为12:20),HC队列24名(男女比例为13:11)。18名患者确定为典型发病。总体而言,平均VTI(±标准差)为0.21(±0.07)。与所有其他亚组相比,典型发病的男性法布里病患者平均VTI显著更高(0.33,标准差±0.35)(P值<0.05)。对法布里病患者视网膜VTI的进一步研究可能有助于将OCTA用作一种非侵入性筛查和随访方式,以评估受影响患者的疾病进展。